264 filings
Page 8 of 14
4
l0krl8y7u nsldkny
16 Oct 20
Change in insider ownership
9:30pm
8-K
c9opy
16 Oct 20
Eton Pharmaceuticals Announces Closing of Public Offering
5:24pm
424B5
7j2jpekvutxby 8740t
15 Oct 20
Prospectus supplement for primary offering
4:50pm
8-K
uu9gbs7cpvj18rfbuv4t
15 Oct 20
Eton Pharmaceuticals Announces Acceptance for Filing of New Drug Application for Zonisamide Oral Suspension
9:15am
8-K
2wd1 afag3k3wzydt3
14 Oct 20
Eton Pharmaceuticals Announces Proposed Public Offering of Common Stock
8:53am
424B5
u8257s yj06bfxd
13 Oct 20
Prospectus supplement for primary offering
4:21pm
8-K
eaq6vohn
8 Oct 20
Eton Pharmaceuticals Announces Acceptance for Filing of New Drug Application for Orphan Drug Dehydrated Alcohol Injection
9:05am
8-K
qnd h6it5p9
6 Oct 20
Other Events
4:56pm
8-K
6la4dyo
30 Sep 20
Other Events
6:15am
8-K
zzu4vuw
25 Sep 20
Other Events
8:23am
8-K
05lecxmei5wu8haj
16 Sep 20
Eton Pharmaceuticals Provides Update on the FDA Review of EM-100
9:28am
8-K
qlqd0d 1ybz1k2
31 Aug 20
Eton Pharmaceuticals Announces Appointment of Ingrid Hoos as Senior Vice President of Scientific Affairs
9:25am
EFFECT
6zzziyy1cqinwxg
26 Aug 20
Notice of effectiveness
12:15am
CORRESP
pd5xdz 8v
24 Aug 20
Correspondence with SEC
12:00am
8-K
l9xgnznk3v3gbtuv5h
12 Aug 20
Eton Pharmaceuticals Announces Second Quarter 2020 Financial Results
8:52am
8-K
vdczxk5lwbkv sra75c
11 Aug 20
Eton Pharmaceuticals Provides Update on the FDA Review of EM-100
9:21am
UPLOAD
gz4hia55xzk3lau
4 Aug 20
Letter from SEC
12:00am
8-K
u3sfgfvglscu3cc2b
31 Jul 20
Other Events
4:25pm